# UCB

> <p><strong>Known for:</strong> Epilepsy drugs like Keppra, Vimpat and Briviact that control seizures, plus Bimzelx for psoriasis and Cimzia for rheumatoid arthritis and Crohn's disease.<br><strong>Employees:</strong> ~9,400</p>

UCB is a Belgian biopharmaceutical company headquartered in Brussels and founded in 1928, listed on Euronext Brussels. The company focuses on neurology, including the epilepsy drugs Vimpat and Briviact and the multiple-sclerosis treatment Bimzelx, and on immunology with Cimzia.

Its epilepsy portfolio in particular is globally relevant.

https://www.ucb.com